-
(2S)-2-[(5-{methyl[(2-methyl-4-oxo-3,4-dihydroquinazolin-6-yl)methyl]amino}thiophen-2-yl)formamido]pentanedioic acid hydrate
-
ChemBase ID:
154385
-
Molecular Formular:
C21H24N4O7S
-
Molecular Mass:
476.50286
-
Monoisotopic Mass:
476.13657013
-
SMILES and InChIs
SMILES:
Cc1[nH]c(=O)c2cc(ccc2n1)CN(C)c1ccc(s1)C(=O)N[C@@H](CCC(=O)O)C(=O)O.O
Canonical SMILES:
OC(=O)CC[C@@H](C(=O)O)NC(=O)c1ccc(s1)N(Cc1ccc2c(c1)c(=O)[nH]c(n2)C)C.O
InChI:
InChI=1S/C21H22N4O6S.H2O/c1-11-22-14-4-3-12(9-13(14)19(28)23-11)10-25(2)17-7-6-16(32-17)20(29)24-15(21(30)31)5-8-18(26)27;/h3-4,6-7,9,15H,5,8,10H2,1-2H3,(H,24,29)(H,26,27)(H,30,31)(H,22,23,28);1H2/t15-;/m0./s1
InChIKey:
VADKIFZZQGWGDT-RSAXXLAASA-N
-
Cite this record
CBID:154385 http://www.chembase.cn/molecule-154385.html
NAMES AND DATABASE IDS
NAMES AND DATABASE IDS
Names Database IDs
|
IUPAC name
|
|
(2S)-2-[(5-{methyl[(2-methyl-4-oxo-3,4-dihydroquinazolin-6-yl)methyl]amino}thiophen-2-yl)formamido]pentanedioic acid hydrate
|
|
|
|
|
IUPAC Traditional name
|
|
(2S)-2-[(5-{methyl[(2-methyl-4-oxo-3H-quinazolin-6-yl)methyl]amino}thiophen-2-yl)formamido]pentanedioic acid hydrate
|
|
|
|
|
Synonyms
|
|
L-Glutamic acid, N-((5-(((1,4-dihydro-2-methyl-4-oxo-6-quinazolinyl)methyl)methylamino)-2-thienyl)carbonyl)- monohydrate
|
|
ICI-D-1694
|
|
ZD-1694
|
|
Raltitrexed monohydrate
|
|
|
|
|
MDL Number
|
|
|
PubChem SID
|
|
|
PubChem CID
|
|
DATA SOURCES
DATA SOURCES
All Sources Commercial Sources Non-commercial Sources
CALCULATED PROPERTIES
CALCULATED PROPERTIES
JChem
|
Acid pKa
|
3.9605484
|
H Acceptors
|
8
|
H Donor
|
4
|
LogD (pH = 5.5)
|
-1.3607305
|
LogD (pH = 7.4)
|
-4.7035975
|
Log P
|
0.7630046
|
Molar Refractivity
|
117.8249 cm3
|
Polarizability
|
43.176983 Å3
|
Polar Surface Area
|
148.4 Å2
|
Rotatable Bonds
|
9
|
Lipinski's Rule of Five
|
true
|
DETAILS
DETAILS
Sigma Aldrich
Sigma Aldrich -
R9156
|
Biochem/physiol Actions Raltitrexed is a folate-based inhibitor of thymidylate synthase (TS) that is rapidly and extensively metabolized to its more potent polyglutamate derivatives. By inhibiting the formation of precursor pyrimidine nucleotides, raltitrexed prevents the formation of DNA and RNA, which are required for the growth and survival of both normal cells and cancer cells. |
PATENTS
PATENTS
PubChem Patent
Google Patent